Clinical Trial Update: Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression [NA]

View source ↗

Summary

An open-label clinical trial evaluating personalized therapeutic neuromodulation for treatment-resistant depression, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Personalized Therapeutic Neuromodulation

Snippet

Sponsor: Stanford University | Conditions: Treatment Resistant Depression | NA | Status: ACTIVE_NOT_RECRUITING